130 related articles for article (PubMed ID: 7654040)
1. PCNA--a cell proliferation marker in vocal chord cancer. Part I: Premalignant laryngeal lesions.
Pignataro LD; Broich G; Lavezzi AM; Biondo B; Ottaviani F
Anticancer Res; 1995; 15(4):1517-20. PubMed ID: 7654040
[TBL] [Abstract][Full Text] [Related]
2. PCNA--a cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions.
Broich G; Lavezzi AM; Biondo B; Pignataro LD
In Vivo; 1996; 10(2):175-8. PubMed ID: 8744797
[TBL] [Abstract][Full Text] [Related]
3. [An immunohistochemical study of proliferating cell nuclear antigen (PCNA) and MIB-1 in epithelial hyperplasia and dysplasia of the vocal cords].
Urano M; Iwata S; Takasu A; Mori S; Sakurai K; Katoh H; Yamamoto S; Kasahara M; Kuroda M; Hakuno T
Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):395-401. PubMed ID: 8934774
[TBL] [Abstract][Full Text] [Related]
4. [Expression of proliferating cell nuclear antigen (PCNA) in premalignant lesions of laryngeal epithelium].
Zhou G; Lin D; Liang C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):206-8. PubMed ID: 8745457
[TBL] [Abstract][Full Text] [Related]
5. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
[TBL] [Abstract][Full Text] [Related]
6. Clinical, morphological and immunohistochemical aspects in laryngeal premalignant lesions.
Anghelina F; Ioniţă E; Popescu CF; Ioniţă I; Mogoantă C; Ciolofan S; Mogoantă L
Rom J Morphol Embryol; 2006; 47(2):169-74. PubMed ID: 17106526
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and anatomopathological course of cancer starting in the vocal cords. Results of treatment].
Szlezak L; Przybora LA
Ann Otolaryngol Chir Cervicofac; 1983; 100(2):115-24. PubMed ID: 6847067
[TBL] [Abstract][Full Text] [Related]
8. Expression of proliferating cell nuclear antigen in premalignant lesions of the larynx.
Zhao R; Hirano M; Kurita S
Am J Otolaryngol; 1996; 17(1):36-44. PubMed ID: 8801814
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
10. A noninvasive procedure for early-stage discrimination of malignant and precancerous vocal fold lesions based on laryngeal dynamics analysis.
Unger J; Lohscheller J; Reiter M; Eder K; Betz CS; Schuster M
Cancer Res; 2015 Jan; 75(1):31-9. PubMed ID: 25371410
[TBL] [Abstract][Full Text] [Related]
11. [The proliferative activity of laryngeal carcinoma and its relationship to histological malignancy and prognosis].
Zhang Q; Li Y; Liu J
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(5):305-7. PubMed ID: 8762515
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability as an indicator of malignant progression in laryngeal premalignancy.
Sardi I; Franchi A; De Campora L; Passali GC; Gallo O
Head Neck; 2006 Aug; 28(8):730-9. PubMed ID: 16721747
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of cathepsin D in laryngeal epithelial lesions: correlation with CD44 expression, p53 and Rb status and proliferation associated indices.
Goussia A; Ioachim E; Peschos D; Assimakopoulos D; Vougiouklakis T; Skevas A; Agnantis N
Anticancer Res; 1999; 19(4B):3055-60. PubMed ID: 10652592
[TBL] [Abstract][Full Text] [Related]
14. Premalignant changes in the vocal cord.
Robbett WF
Laryngoscope; 1972 Jun; 82(6):1007-12. PubMed ID: 5036232
[No Abstract] [Full Text] [Related]
15. Proliferating cell nuclear antigen (PCNA) expression in laryngeal squamous cell carcinomas. An immunohistochemical study.
Kram A; Domagała W
Pol J Pathol; 1996; 47(4):183-7. PubMed ID: 9097710
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of proliferating cell nuclear antigen (PCNA) in supraglottic carcinoma.
Liu M; Lawson G; Delos M; Jamart J; Remacle M
Acta Otorhinolaryngol Belg; 1997; 51(3):129-35. PubMed ID: 9350310
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinoma - an aid to conventional histological grading?
Zain RB; Sakamoto F; Shrestha P; Mori M
Malays J Pathol; 1995 Jun; 17(1):23-30. PubMed ID: 8907001
[TBL] [Abstract][Full Text] [Related]
18. Difficulties in management of vocal cord precancerous lesions.
Kambic V
J Laryngol Otol; 1978 Apr; 92(4):305-15. PubMed ID: 641413
[TBL] [Abstract][Full Text] [Related]
19. Fibroblasts can modulate the phenotype of malignant epithelial cells in vitro.
Atula S; Grenman R; Syrjänen S
Exp Cell Res; 1997 Aug; 235(1):180-7. PubMed ID: 9281367
[TBL] [Abstract][Full Text] [Related]
20. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]